Skip to main content
Clinical Trials/NCT04195932
NCT04195932
Completed
Not Applicable

Exercise as a Modulator of Immune Risk Factors for Ischemic Heart Disease

East Tennessee State University1 site in 1 country52 target enrollmentDecember 1996
ConditionsHeart Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Diseases
Sponsor
East Tennessee State University
Enrollment
52
Locations
1
Primary Endpoint
Effect of exercise on atherogenic cytokine production by mitogen-stimulated peripheral blood mononuclear cells
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

A before and after study involving 43 adult subjects at risk of having ischemic heart disease. Subjects underwent 6 months of supervised moderate intensity aerobic and resistive exercise training. Blood samples were obtained at entry and at 6 months for measurement of complement (C3), CRP, blood lipid levels, lymphocyte phenotypes, and for the isolation, culture, and measurement of the spontaneous and phytohemagglutinin-induced secretion of proatherogenic and antiatherogenic cytokines by their peripheral blood mononuclear cells (PBMC).

Detailed Description

A before and after study involving 43 adult subjects at risk of having ischemic heart disease. Subjects underwent 6 months of supervised moderate intensity aerobic and resistive exercise training. Blood samples were obtained at entry and at 6 months for measurement of complement (C3), CRP, blood lipid levels, lymphocyte phenotypes, and for the isolation, culture, and measurement of the spontaneous and phytohemagglutinin-induced secretion of proatherogenic and antiatherogenic cytokines by their peripheral blood mononuclear cells (PBMC

Registry
clinicaltrials.gov
Start Date
December 1996
End Date
May 1998
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

John Kelly Smith

Emeritus Professor of Medicine

East Tennessee State University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • abnormal EKG
  • abnormal stress test
  • presence of a chronic inflammatory disease
  • presence of malignancy
  • immunosuppressive therapy

Outcomes

Primary Outcomes

Effect of exercise on atherogenic cytokine production by mitogen-stimulated peripheral blood mononuclear cells

Time Frame: 1 year

Pre- and post-exercise peripheral blood mononuclear cell (PBMC) preparations are isolated from venous blood, washed three times at 10 degrees C with sterile phosphate buffered saline (pH 7.4, 0.1 M) and suspended at a concentration of 2 million cells/uL in RPMI-1640. Preparations are incubated under 5% CO2 at 37 degrees C for 48 hours with phytohemagglutinin (5 ug/ml). Culture supernatants are rendered cell-free and supernatants assayed for Interleukin (IL)-1α, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ using solid phase enzyme linked immunoassay kits.

Effect of exercise on plasma lipids and oxidizable low density lipoprotein cholesterol levels

Time Frame: 1 year

Pre- and post-exercise fasting plasma levels of total cholesterol (TC), very low density lipoprotein cholesterol (VLDL), low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C) levels are measured using g-Max Quick-Seal tubes and potassium bromide (KBr) (d=1.006 g/mL). Tubes are centrifuged for 120 minutes at 68,000 rpm at 14 degrees C. The top layer (VLDL) is harvested, the bottom 3.7 mL adjusted to a density of 1.063 g/mL with KBr, and the tubes centrifuged for 150 minutes at 68,000 rpm at 14 degrees C to float the LDL-C. The bottom layer contains the HDL-C. TC, VLDL-C, LDL-C, and HDL concentrations are measured colorimetrically. LDL oxidizability is measured by oxidizing LDL-C (0.05 g/L) with 50 ug/mL Cu++ at 30 degrees C and measuring diene levels spectrometrically at 234 nm.

Secondary Outcomes

  • Effect of exercise on blood lymphocyte phenotypes(1 year)

Study Sites (1)

Loading locations...

Similar Trials